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Protein expression of IL-6 and IL- 17 were down-regulated
in all treatment groups signiﬁcantly(P<0.01). Protein expres-
sion of TNF- were down- regulated in positive group and
high-dose groups signiﬁcantly (P<0.01).
Conclusion: Simiao Yong’an decoction shows a certain
therapeutic effect on CIA rats, it’s anti-inﬂammatory action
mechanism may achieve by reducing expression of IL-6,IL-17
and TNF-.
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Inﬂuence of baicalein on pharmacokinetics of
ciproﬂoxacin after single oral administration
in rats
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Hye Jin Yang, Jin Yeul Ma
Korea Institute of Oriental Medicine
Purpose: Baicalein from Baikal skullcap iss a potent
antibacterial agent with broad-spectrum activity. The com-
bination of baicalein and ciproﬂoxacin can be an excellent
antibacterial chemotherapy against multi-drug resistance
bacteria. We investigated the effect of baicalein on the phar-
macokinetics of ciproﬂoxacin in rats.
Methods: Baicalein and ciproﬂoxacin were orally co-
administered to rats. Pharmacokinetic data were estimated
by non- compartmental model.
Results: Baicalein signiﬁcantly decreased AUC0→∞ of
ciproﬂoxacin after oral administration (P<0.05). Therelative
bioavailability (Frel) of ciproﬂoxacin after co-administration of
baicalein decreased more than approximately 30% in a dose-
dependent manner.
Conclusion: Based on our ﬁndings, the co-administration
of baicalein may have clinical implications on the dosing of
ciproﬂoxacin or other quinolone antibiotics.
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Hepatoprotective Effect of Herb Formula
KIOM2012H Against Nonalcoholic Fatty Liver
Disease
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Purpose:Nonalcoholic fatty liver disease is hepatic ailment
ofwhich incidence is rapidly increase due to the dietary hyper-
nutrition and following obesity. Fatty liver disease can lead to
steatohepatitis, ﬁbrosis, cirrhosis, and even cancer, which is
associated with various complications. Discovering effective
natural materials and herbs can be alternative and comple-
mentary medical treatment in addition or instead of current
chemical pharmaceuticals.
Methods: To develop effective natural agent for nonalco-
holic fatty liver disease, we formulated combination of four
herb mixture (KIOM2012H) and observed lipid-lowering efﬁ-
cacy. Inhibitory effect of KIOM2012Hon free fatty acid-induced
lipid accumulation, triglyceride contents, and gene expres-
sions were analyzed in HepG2 cells. Using high fat diet-fed
mice, body weight changes, gross liver appearances, hepatic
triglyceride contents, and gene expressions were observed.
Results: KIOM2012H dose-dependently inhibited lipid
accumulation and gene expressions involved in lipogenesis
and related regulators. Experimental animals also showed
decrease of body weight changes and lipid-associated phys-
iological parameters.
Conclusion: Present study shows that KIOM2012H has
alleviating effect on fatty acid and lipid accumulation, and
therefore can be applied for development of new therapeu-
tic pharmaceuticals for treatment of nonalcoholic fatty liver
disease using natural products and herbs.
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Epimedium koreanum Nakai displays broad
spectrum of antiviral activity in vitro and
in vivo by inducing cellular antiviral state
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Purpose: The objective of this study was to determine
the broad spectrum of antiviral activity of the total aqueous
extract of Epimedium Koreanum Nakai in vitro and in BALB/c
mice.
Methods: Green Fluorescent Protein (GFP)-tagged viruses
including Inﬂuenza A (A/PuertoRico/8/34(H1N1)(PR8-GFP),
NDV (Newcastle Disease Virus)-GFP, VSV (Vesicular Stomatitis
Virus)-GFP, Herpes Simplex Virus and Challenge viruses
[A/Aquaticbird/Korea/W81/2005(H5N2), A/PR/8/34(H1N1),
A/Aquaticbird/ Korea/W44/2005(H7N3), and A/Chicken/Korea/
116/2004(H9N2)] were used to examine the antiviral efﬁcacy of
Epimedium Koreanum Nakai. Antiviral effects were evaluated
in viral replication, cell viability and viral gene expression
level. Immune stimulating effects of Epimedium Koreanum
Nakai were determined using ELISA for cytokines such as
murine tumor necrosis factor-alpha (TNF-), interleukin (IL)-6
and inferferon (IFN)-. In vivo antiviral effect on inﬂuenza
virus was tested using oral administration of extracts to mice
intra-nasally infected with 50% mouse lethal dose (MLD50) of
H1N1, H5N2, H7N3 or H9N2.
Results: Epimedium Koreanum Nakai signiﬁcantly sup-
pressed the replication of PR8, VSV, HSV and NDV in RAW264.7
and HEK293T cells. Epimedium Koreanum Nakai induced the
production of type I interferon and pro-inﬂammatory
cytokines at both the mRNA and protein levels and the
transcriptional levels of various ISGs and antiviral genes.
Additionally, the extract induced the phosphorylation of
